^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ASP1002

    i
    Other names: ASP1002, ASP 1002, ASP-1002
    Associations
    News

    Trials

    Company:
    Astellas
    Drug class:
    CD137 agonist, CLDN4 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Study of ASP1002 in Adults for Treatment of Solid Tumors (NCT05719558)
    Phase 1
    Astellas Pharma Global Development, Inc.
    Recruiting
    Last update posted :
    02/19/2025
    Initiation :
    03/13/2023
    Primary completion :
    04/30/2028
    Completion :
    05/31/2028
    HER-2 • ER • PGR
    |
    HER-2 negative
    |
    ASP1002